Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.44 |
| ▸ | ACACA | Q13085 | 1/20 | 0.44 |
| ▸ | ACLY | P53396 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4106618 | 0.81 | CHRM1 (0.41) | CA2MAPK1CYP2C9HSD17B10 | |
| SCHEMBL8689396 | 0.80 | TSHR (0.38) | ACACBACACACA2MAPK1CYP2C9 | |
| SCHEMBL8842792 | 0.76 | CA2 (0.45) | CA2MAPK1 | |
| SCHEMBL6856895 | 0.76 | CA2 (0.36) | ACACBACACACA2MAPK1CYP2C9 | |
| SCHEMBL9710087 | 0.75 | ACACB (0.47) | ACACBACACAACLYCA2MAPK1 | |
| SCHEMBL7048284 | 0.75 | ACACB (0.57) | ACACBACACAACLYCA2MAPK1 | |
| SCHEMBL11207680 | 0.74 | CA2 (0.32) | CA2MAPK1CYP2C9HSD17B10 | |
| SCHEMBL22181478 | 0.74 | GPR84 (0.47) | CA2MAPK1 | |
| SCHEMBL6206221 | 0.73 | ACACB (0.46) | ACACBACACAACLYCA2MAPK1 | |
| SCHEMBL9871824 | 0.73 | CA2 (0.34) | ACACBACACACA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003104503-A1 | INHIBITION OF THE DEPLETION OF PRECIOUS METAL VALUES FROM PREGNANT LIXIVIANT SOLUTIONS | GE BETZ, INC. (US) | 2003-12-18 | — | — | WO | claimed |